- Home
- BNR vs NMTC Comparison
BNR vs NMTC Comparison
Compare BNR & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BNR
- NMTC
- Stock Information
- Founded
- BNR 2014
- NMTC 2009
- Country
- BNR China
- NMTC United States
- Employees
- BNR N/A
- NMTC N/A
- Industry
- BNR Medical Specialities
- NMTC Medical/Dental Instruments
- Sector
- BNR Health Care
- NMTC Health Care
- Exchange
- BNR Nasdaq
- NMTC Nasdaq
- Market Cap
- BNR 38.3M
- NMTC 33.8M
- IPO Year
- BNR 2020
- NMTC N/A
- Fundamental
- Price
- BNR $4.60
- NMTC $0.72
- Analyst Decision
- BNR
- NMTC Strong Buy
- Analyst Count
- BNR 0
- NMTC 1
- Target Price
- BNR N/A
- NMTC $1.45
- AVG Volume (30 Days)
- BNR 19.9K
- NMTC 179.3K
- Earning Date
- BNR 08-21-2025
- NMTC 08-13-2025
- Dividend Yield
- BNR N/A
- NMTC N/A
- EPS Growth
- BNR N/A
- NMTC N/A
- EPS
- BNR N/A
- NMTC N/A
- Revenue
- BNR $72,112,038.00
- NMTC $5,758,777.00
- Revenue This Year
- BNR $136.32
- NMTC $157.28
- Revenue Next Year
- BNR N/A
- NMTC $41.79
- P/E Ratio
- BNR N/A
- NMTC N/A
- Revenue Growth
- BNR 0.53
- NMTC 54.53
- 52 Week Low
- BNR $2.18
- NMTC $0.40
- 52 Week High
- BNR $7.90
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- BNR 68.63
- NMTC 57.22
- Support Level
- BNR $3.06
- NMTC $0.69
- Resistance Level
- BNR $4.96
- NMTC $0.77
- Average True Range (ATR)
- BNR 0.27
- NMTC 0.04
- MACD
- BNR 0.13
- NMTC -0.00
- Stochastic Oscillator
- BNR 81.05
- NMTC 53.50
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through company's in-hospital model and smaller hospitals through its central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.